InvestorsHub Logo
Followers 4
Posts 201
Boards Moderated 0
Alias Born 06/21/2020

Re: None

Monday, 10/26/2020 3:04:37 PM

Monday, October 26, 2020 3:04:37 PM

Post# of 232963
About our chief scientific officer Mr Rahman

“In 2013, he joined Novartis as a Vice President and the Therapeutic Area Head for Immunology and Musculoskeletal Disease, where he was involved in the development of several compounds of which two achieved FDA and EMA approval for marketing, Canakinumab and secukinumab in several indications. I”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News